Optimizing the opportunity for female fertility preservation in a limited time-frame for patients with cancer using in vitro maturation and ovarian tissue cryopreservation


Like Comment

Volume 111, Issue 2, Pages 258–259


Roger J. Hart, M.D.


Reflections on "Serum AMH is associated with the number of oocytes, matured in vitro and with primordial follicle density in candidates for fertility preservation" by Sermondade et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.


Go to the profile of Hiren Prajapati
about 2 years ago

my concern is for those young patients who are standing low at their ovarian reserve and you have very well discussed many aspects of challenges ,how do you plan management with low AMH and few AFC